BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 31648589)

  • 1. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
    Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
    Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
    Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
    J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability.
    Guimarães PP; Oliveira SR; de Castro Rodrigues G; Gontijo SM; Lula IS; Cortés ME; Denadai ÂM; Sinisterra RD
    Molecules; 2015 Jan; 20(1):879-99. PubMed ID: 25580685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
    Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
    Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
    Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
    Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
    Badran MM; Mady MM; Ghannam MM; Shakeel F
    Int J Biol Macromol; 2017 Feb; 95():643-649. PubMed ID: 27908720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
    El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
    Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil.
    Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE
    IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
    Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
    J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.
    Alizadeh B; Bahari Javan N; Akbari Javar H; Khoshayand MR; Dorkoosh F
    Pharm Dev Technol; 2018 Feb; 23(2):132-144. PubMed ID: 28430010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.